| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fd652ddebabfa3b8c8aa4b21d69b862 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
2019-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0168927aea82d0561a1ea6f2673e1748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2017cae8cb4ccc4062ccb20345251aa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdb815999da551e8613b57de2304b725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8df54440f2a2bce87c05513e141b843c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b77b9fdac278b60a4118c4449191670
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_becdc4808572ad3515080ef8a0cef144 |
| publicationDate |
2021-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2019292207-A1 |
| titleOfInvention |
Pyridopyrimidinone derivatives for use as Axl inhibitors |
| abstract |
Pyridopyrimidinone derivatives and pharmaceutical compositions comprising the same for use as an Axl inhibitor for the treatment of a disease or condition mediated by Axl such as multiple types of cancer and metastasis, are disclosed. Also disclosed are methods for treating a Axl-mediated disease or condition by administering to a subject a therapeutically effective amount of the pyridopyrimidinone derivatives. |
| priorityDate |
2018-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |